Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-Glucans

Theodore J. Kottom, Eva M. Carmona, Andrew H. Limper

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-Glucans'. Together they form a unique fingerprint.

Medicine & Life Sciences